THC
Tenet Healthcare Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+29/100
Last price
258.47
▼ 1.00 (0.39%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
259.00
Prev close
259.47
Day high
263.46
Day low
257.06
Volume
426.76K
Market cap
$20.81B
P/E (TTM)
9.95
52W range
157.58 – 283.05
Day trading desk
Gap from prior close
-0.18%
Prior close 259.47
VWAP
259.53
-0.41% from price
Relative volume
0.79×
Normal
Session range
2.49%
257.06 – 263.46
Position in range
22%
Near session low
ATR (14D)
7.20
2.79% of price
Prior day high
264.45
PDH
Prior day low
258.75
PDL
Bid / ask spread
—
Quote not published
Session volume
770.80K
Avg 974.83K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.34%
-1.6%
1M
-2.48%
-3.6%
3M
+25.31%
+20.8%
6M
+32.82%
+14.6%
YTD
+30.07%
+15.8%
1Y
+27.33%
+10.9%
3Y
+292.28%
+210.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on THC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-179.71K
Net selling
Buy transactions
12
15.12K shares
Sell transactions
14
194.84K shares
Net transactions
+26
Buys less sells
Sell : buy shares
12.9 : 1
Heavily one-sided
Insider-held shares
780.23K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 14, 26 | KERREY JOSEPH ROBERT Director |
SELL | 12.01K | $3.17M | Direct |
| Sep 10, 26 | MARK RICHARD J Director |
SELL | 10.00K | $2.63M | Direct |
| Sep 2, 26 | WEST NADJA Y. Director |
SELL | 1.15K | $298.14K | Direct |
| Aug 31, 26 | FOO LISA Y Chief Operating Officer |
SELL | 24.00K | $6.39M | Direct |
| Aug 28, 26 | HANEY CECIL D. Director |
STOCK | 150 | $0 | Direct |
| Aug 25, 26 | SUTARIA SAUMYA Chief Executive Officer |
SELL | 100.00K | $27.64M | Direct |
| Aug 24, 26 | HANEY CECIL D. Director |
SELL | 1.30K | $361.44K | Direct |
| Aug 7, 26 | ROMO TAMMY Director |
SELL | 7.42K | $1.95M | Direct |
| Aug 5, 26 | BLUNT ROY Director |
SELL | 600 | $157.61K | Direct |
| Jul 29, 26 | FOO LISA Y Chief Operating Officer |
SELL | 10.00K | $2.58M | Direct |
| Jul 27, 26 | BIERMAN JAMES L Director |
SELL | 5.00K | $1.22M | Direct |
| Jul 27, 26 | LYNCH CHRISTOPHER S Director |
SELL | 3.84K | $934.08K | Direct |
| Jul 27, 26 | ARBOUR PAOLA M Chief Technology Officer |
SELL | 10.88K | $2.65M | Direct |
| May 28, 26 | KERREY JOSEPH ROBERT Director |
SELL | 5.64K | $983.92K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ARBOUR PAOLA M |
Chief Technology Officer | 18.41K | Sale |
BIERMAN JAMES L |
Director | 31.60K | Sale |
FISHER RICHARD W. |
Director | 9.63K | Conversion of Exercise of derivative security |
FITZGERALD MEGHAN |
Director | 17.09K | Conversion of Exercise of derivative security |
HANEY CECIL D. |
Director | 12.40K | Stock Gift |
MARK RICHARD J |
Director | 25.12K | Sale |
PARK SUN |
Chief Financial Officer | 19.44K | Conversion of Exercise of derivative security |
ROMO TAMMY |
Director | 28.28K | Sale |
SUTARIA SAUMYA |
Chief Executive Officer | 433.56K | Sale |
WEST NADJA Y. |
Director | 23.65K | Sale |
Fundamentals
Market cap$20.81B
Enterprise value$35.93B
Revenue (TTM)$21.81B
Gross profit$9.09B
EBITDA$4.84B
Net income$2.24B
EPS (TTM)$25.97
Free cash flow$2.25B
Total cash$2.17B
Total debt$13.25B
Book value / share$57.86
Shares outstanding80.52M
Float79.68M
Short % of float2.94%
Dividend yield0.00%
Beta (5Y)1.20
Valuation & profitability ratios
Trailing P/E9.95
Forward P/E12.26
PEG ratio1.80
Price / sales—
Price / book4.47
EV / revenue1.65
EV / EBITDA7.42
Gross margin41.66%
Operating margin18.16%
Profit margin10.27%
Return on equity37.34%
Return on assets8.32%
Debt / equity152.28
Current ratio1.41
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $21.31B | $20.68B | $20.56B | $19.17B | +3.1% |
| Operating revenue | $21.31B | $20.68B | $20.56B | $19.17B | +3.1% |
| Cost of revenue | $3.78B | $3.65B | $3.59B | $3.27B | +3.6% |
| Gross profit | $17.53B | $17.03B | $16.97B | $15.90B | +2.9% |
| Selling, general & admin | $8.71B | $8.80B | $9.15B | $8.84B | -1.1% |
| Total operating expense | $14.09B | $14.11B | $14.53B | $13.49B | -0.1% |
| Operating income | $3.44B | $2.92B | $2.44B | $2.41B | +17.9% |
| Net interest income | -$821.00M | -$826.00M | -$901.00M | -$890.00M | +0.6% |
| Pre-tax income | $2.80B | $5.25B | $1.62B | $1.34B | -46.6% |
| Tax provision | $433.00M | $1.18B | $306.00M | $344.00M | -63.4% |
| Net income | $1.41B | $3.20B | $611.00M | $411.00M | -56.0% |
| Net income to common | $1.41B | $3.20B | $611.00M | $411.00M | -56.0% |
| Basic EPS | 15.61 | 33.02 | 6.01 | 3.84 | -52.7% |
| Diluted EPS | 15.49 | 32.70 | 5.71 | 3.79 | -52.6% |
| EBIT | $3.62B | $6.07B | $2.52B | $2.23B | -40.4% |
| EBITDA | $4.48B | $6.89B | $3.39B | $3.08B | -34.9% |
| Basic shares | 90.15M | 96.90M | 101.64M | 106.93M | -7.0% |
| Diluted shares | 90.83M | 97.88M | 104.80M | 110.52M | -7.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.88B | $3.02B | $1.23B | $858.00M | -4.5% |
| Cash & short-term investments | $2.88B | $3.02B | $1.23B | $858.00M | -4.5% |
| Accounts receivable | $2.56B | $2.54B | $2.91B | $2.94B | +1.1% |
| Inventory | $348.00M | $346.00M | $411.00M | $405.00M | +0.6% |
| Total current assets | $7.85B | $7.68B | $7.17B | $5.98B | +2.2% |
| Property, plant & equipment | $7.45B | $7.09B | $7.32B | $7.59B | +5.1% |
| Goodwill & intangibles | $12.55B | $12.09B | $11.68B | $11.55B | +3.8% |
| Total assets | $29.68B | $28.94B | $28.31B | $27.16B | +2.6% |
| Total current liabilities | $4.46B | $4.31B | $4.76B | $4.48B | +3.5% |
| Current debt | $79.00M | $92.00M | $120.00M | $145.00M | -14.1% |
| Long-term debt | $13.09B | $13.08B | $14.88B | $14.93B | +0.1% |
| Total debt | $13.17B | $13.17B | $15.00B | $15.08B | -0.0% |
| Total liabilities | $20.70B | $20.39B | $22.80B | $22.55B | +1.5% |
| Retained earnings | $4.42B | $3.01B | -$192.00M | -$803.00M | +46.8% |
| Shareholder equity | $4.22B | $4.17B | $1.61B | $1.14B | +1.2% |
| Working capital | $3.39B | $3.37B | $2.41B | $1.50B | +0.4% |
| Net tangible assets | -$8.33B | -$7.92B | -$10.07B | -$10.40B | -5.2% |
| Shares issued | 158.61M | 158.00M | 157.27M | 156.46M | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $2.37B | $4.06B | $1.31B | $1.00B | -41.8% |
| Depreciation & amortisation | $863.00M | $818.00M | $870.00M | $841.00M | +5.5% |
| Stock-based compensation | $104.00M | $67.00M | $66.00M | $56.00M | +55.2% |
| Change in working capital | $140.00M | $136.00M | $71.00M | -$1.14B | +2.9% |
| Operating cash flow | $3.54B | $2.05B | $2.37B | $1.08B | +72.9% |
| Capital expenditure | -$1.01B | -$931.00M | -$751.00M | -$762.00M | -8.5% |
| Investing cash flow | -$1.27B | $3.43B | -$969.00M | -$808.00M | -137.2% |
| Share buybacks | -$1.39B | -$672.00M | -$200.00M | -$250.00M | -106.3% |
| Financing cash flow | -$2.40B | -$3.69B | -$1.03B | -$1.78B | +34.8% |
| Free cash flow | $2.53B | $1.12B | $1.62B | $321.00M | +126.7% |
| End cash position | $2.88B | $3.02B | $1.23B | $858.00M | -4.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $6.04B | $5.78B | $5.53B | $5.29B | $5.27B | +4.5% |
| Operating revenue | $6.04B | $5.78B | $5.53B | $5.29B | $5.27B | +4.5% |
| Cost of revenue | $984.00M | $961.00M | $1.01B | $931.00M | $932.00M | +2.4% |
| Gross profit | $5.06B | $4.82B | $4.52B | $4.36B | $4.34B | +4.9% |
| Selling, general & admin | $2.23B | $2.17B | $2.22B | $2.20B | $2.16B | +2.6% |
| Total operating expense | $3.62B | $3.52B | $3.65B | $3.54B | $3.49B | +2.7% |
| Operating income | $1.44B | $1.29B | $869.00M | $817.00M | $852.00M | +11.0% |
| Net interest income | -$204.00M | -$205.00M | -$205.00M | -$206.00M | -$206.00M | +0.5% |
| Pre-tax income | $1.34B | $1.13B | $681.00M | $712.00M | $642.00M | +18.4% |
| Tax provision | $295.00M | $226.00M | $37.00M | $133.00M | $120.00M | +30.5% |
| Net income | $826.00M | $702.00M | $371.00M | $342.00M | $288.00M | +17.7% |
| Net income to common | $826.00M | $702.00M | $371.00M | $342.00M | $288.00M | +17.7% |
| Basic EPS | 9.89 | 8.09 | 4.25 | 3.89 | 3.16 | +22.2% |
| Diluted EPS | 9.84 | 8.01 | 4.22 | 3.86 | 3.14 | +22.8% |
| EBIT | $1.54B | $1.34B | $886.00M | $918.00M | $848.00M | +15.5% |
| EBITDA | $1.76B | $1.57B | $1.12B | $1.14B | $1.06B | +12.3% |
| Basic shares | 83.52M | 86.80M | 87.27M | 87.95M | 91.14M | -3.8% |
| Diluted shares | 83.96M | 87.60M | 87.92M | 88.61M | 91.79M | -4.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.17B | $2.97B | $2.88B | $2.98B | $2.63B | -26.9% |
| Cash & short-term investments | $2.17B | $2.97B | $2.88B | $2.98B | $2.63B | -26.9% |
| Accounts receivable | $2.61B | $2.60B | $2.56B | $2.52B | $2.53B | +0.1% |
| Inventory | $338.00M | $343.00M | $348.00M | $346.00M | $338.00M | -1.5% |
| Total current assets | $7.83B | $8.36B | $7.85B | $7.81B | $7.30B | -6.3% |
| Property, plant & equipment | $6.26B | $6.25B | $7.45B | $6.09B | $6.02B | +0.1% |
| Goodwill & intangibles | $12.72B | $12.70B | $12.55B | $12.51B | $12.31B | +0.1% |
| Total assets | $30.68B | $31.20B | $29.68B | $29.42B | $28.70B | -1.7% |
| Total current liabilities | $5.57B | $6.15B | $4.46B | $4.56B | $4.27B | -9.5% |
| Current debt | $160.00M | $81.00M | $79.00M | $85.00M | $84.00M | +97.5% |
| Long-term debt | $13.09B | $13.13B | $13.09B | $13.10B | $13.09B | -0.3% |
| Total debt | $13.25B | $13.21B | $13.17B | $13.19B | $13.18B | +0.3% |
| Total liabilities | $21.98B | $22.35B | $20.70B | $20.72B | $20.40B | -1.7% |
| Retained earnings | $5.94B | $5.12B | $4.42B | $4.04B | $3.70B | +16.1% |
| Shareholder equity | $4.66B | $4.81B | $4.22B | $4.01B | $3.75B | -3.2% |
| Working capital | $2.26B | $2.20B | $3.39B | $3.25B | $3.03B | +2.5% |
| Net tangible assets | -$8.06B | -$7.89B | -$8.33B | -$8.49B | -$8.56B | -2.2% |
| Shares issued | 80.51M | 159.13M | 158.61M | 158.59M | 158.47M | -49.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.04B | $906.00M | $644.00M | $579.00M | $522.00M | +15.3% |
| Depreciation & amortisation | $215.00M | $229.00M | $231.00M | $218.00M | $208.00M | -6.1% |
| Stock-based compensation | $44.00M | $25.00M | $25.00M | $38.00M | $20.00M | +76.0% |
| Change in working capital | -$785.00M | $493.00M | -$172.00M | $197.00M | $144.00M | -259.2% |
| Operating cash flow | $585.00M | $1.64B | $731.00M | $1.06B | $936.00M | -64.4% |
| Capital expenditure | -$168.00M | -$180.00M | -$364.00M | -$280.00M | -$193.00M | +6.7% |
| Investing cash flow | -$203.00M | -$317.00M | -$389.00M | -$385.00M | -$314.00M | +36.0% |
| Share buybacks | -$1.04B | -$318.00M | -$198.00M | -$93.00M | -$747.00M | -227.7% |
| Financing cash flow | -$1.18B | -$1.24B | -$434.00M | -$323.00M | -$996.00M | +4.9% |
| Free cash flow | $417.00M | $1.46B | $367.00M | $778.00M | $743.00M | -71.5% |
| End cash position | $2.17B | $2.97B | $2.88B | $2.98B | $2.63B | -26.9% |
Options analytics
Put / call volume
2.00
Put-heavy session
Put / call open interest
1.72
Positioning, not flow
Max pain
270.00
+4.5% from spot
ATM implied vol
47.6%
Nearest strike to spot
Skew (10% OTM)
+5.2%
Puts bid over calls
Call volume
32
Contracts, this expiry
Put volume
64
Contracts, this expiry
Heaviest call OI
270.00
818 contracts
Heaviest put OI
260.00
852 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 4.26 | 6.12 | +43.5% |
| Mar 2026 | 4.17 | 4.82 | +15.7% |
| Dec 2025 | 4.07 | 4.70 | +15.6% |
| Sep 2025 | 3.35 | 3.70 | +10.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 4.67 | 20 | $5.51B | +4.2% |
| Next quarter | 5.67 | 20 | $5.77B | +4.3% |
| Current year | 21.22 | 21 | $22.43B | +5.3% |
| Next year | 21.08 | 21 | $22.52B | +0.4% |
Analyst targets & ownership
Mean target$284.64
High target$315.00
Low target$260.00
Implied upside10.12%
Analyst count22
ConsensusBUY
Strong buy / Buy5 / 14
Hold4
Sell / Strong sell0 / 0
Held by insiders0.97%
Held by institutions101.99%
Institutions holding895
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
256.73
+0.68% from price
SMA 20
260.08
-0.62% from price
SMA 50
262.56
-1.56% from price
SMA 100
224.74
+15.01% from price
SMA 200
214.11
+20.72% from price
EMA 12
258.39
+0.03% from price
EMA 26
258.95
-0.18% from price
EMA 50
252.38
+2.41% from price
RSI (14)
49.6
Neutral
MACD (12,26,9)
-0.56
Hist -0.53
ATR (14)
7.20
2.79% of price
Realised vol 30D
27.1%
Annualised
Bollinger upper
268.66
20, 2σ
Bollinger lower
251.50
20, 2σ
50 / 200 cross
Golden
262.56 vs 214.11
Trend bias
Above 200
+20.72%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.51
Less volatile than market
Correlation to SPY
0.15
Largely independent
Realised vol 30D
27.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-34.1%
Peak to trough
Max drawdown 5Y
-58.9%
Peak to trough
ATR 14
7.20
2.79% of price
Beta (reported)
1.20
5Y monthly, from filing
Short interest
Shares short
2.02M
Prior 2.52M
Change vs prior
-20.1%
Shorts covering
% of float
2.94%
Normal
% of shares out
2.50%
Against total outstanding
Days to cover
2.8
Liquid
Float
79.68M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 26 | BMO Capital | INITIATED | — | Market Perform |
| Sep 18, 26 | Leerink Partners | MAINTAINED | Outperform | Outperform |
| Aug 3, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 28, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 28, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Jul 28, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 27, 26 | UBS | MAINTAINED | Buy | Buy |
| Jul 27, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 27, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 27, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 24, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 20, 26 | Guggenheim | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield2.21%
Payout ratio0.00%
Ex-dividend dateMar 13, 2000
Next pay date—
Last split1:4
Split dateOct 11, 2012
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-22
Corporate Changes & Voting Matters
8-K · 2026-09-08
Periodic Financial Reports
10-Q · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-23
Corporate Changes & Voting Matters
8-K · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-04-30
Proxy Statements
DEFA14A · 2026-04-16
Corporate Changes & Voting Matters
8-K · 2026-04-10
Headlines
Tenet Upgrades Full Year 2026 Revenue Guidance Following Latest Operating Results and Developments
TMX Newsfile · 16h ago
Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know
Zacks · 4d ago
Tenet to Report Its Third Quarter 2026 Results on October 29
Business Wire · 5d ago
Tenet Healthcare (THC): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 5d ago
Tenet Adds First U.S. Exclusive Commercial Lender to Business Hub and Welcomes New West Coast Business Development Manager
TMX Newsfile · 6d ago
Can THC's Cash Flow Support Its Expanding Capital-Return Strategy?
Zacks · 7d ago
Can Shorter Hospital Stays Help HCA Handle More Patient Demand?
Zacks · 9d ago
Is Tenet Healthcare (THC) Outperforming Other Medical Stocks This Year?
Zacks · 9d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.